Disruption of TGFβ signaling pathways in human pancreatic cancer cells

Annals of Surgery

Volumn 232, Issue 1, 2000, Pages 73-80

  Simeone, Diane M ^a,b   Pham, Trinh ^a   Logsdon, Craig D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; DNA BINDING PROTEIN; MADH2 PROTEIN, RAT; MADH3 PROTEIN, RAT; MADH4 PROTEIN, RAT; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CANCER IMMUNOLOGY; CONTROLLED STUDY; GENE DISRUPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; RAT; REPORTER GENE; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; GENETIC TRANSFECTION; GENETICS; PANCREAS TUMOR; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; DNA-BINDING PROTEINS; HUMANS; PANCREATIC NEOPLASMS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0033623872     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200007000-00011     Document Type: Article

References (35)

1. Yeo CJ. Pancreatic cancer: 1998 update. J Am Coll Surg 1998; 187:429-442.
2. Massague J, Attisano L, Wrana JL. The TGFβ family and its composite receptors. Trends Cell Biol 1994; 4:172-178.
3. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 1994; 371:257-261.
4. Datto MB, Yu Y, Wang XF. Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem 1995; 270:28623-28628.
5. Reynisdottir I, Polyak K, lavarone A, Massague J. Kip/Cip and Ink4 CDK inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev 1995; 9:1831-1845.
6. Iavarone A, Massague J. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 1997; 387:417-426.
7. Logsdon CD, Keyes L, Beauchamp RD. Tranforming growth factor-β (TGF-β1) inhibits pancreatic acinar cell growth. Am J Physiol 1992; 262:G364-368.
8. Bisgaard Hc, Thorgeirsson SS. Evidence for a common cell of origin for primitive epithelial cells isolated from rat liver and pancreas. J Cell Physiol 1991; 147:333-343.
9. Markowitz S, Wang J, Myeroff L, et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995; 268:1336-1338.
10. Park K. Kim SJ, Bang YJ, et al. Genetic changes in the transforming growth factor β (TGFβ) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGFβ. Proc Natl Acad Sci U S A 1994; 91:8772-8776.
11. Hoodless PA, Wrana JL. Mechanism and function of signaling by the TGFβ superfamily. Curr Topics Microbiol Immunol 1998; 228:235-272.
12. Hahn SA, Schutte M, Hoque S, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271:350-353.
13. Eppert K, Scherer SW, Ozcelik H, et al. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal cancer. Cell 1996; 86:543-552.
14. Beauchamp RD, Lyons RM, Yang EY, et al. Expression of and response to growth regulatory peptides by two human pancreatic-carcinoma cell lines. Pancreas 1990; 5:369-380.
15. Baldwin RL, Friess H, Yokoyama M, et al. Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. Int J Cancer 1996; 67:283-288.
16. Willis SA, Zimmennan CM, Li L, Mathews LS. Formation and activation by phosphorylation of activin receptor complexes. Mol Endocrinol 1996; 10:367-379.
17. Williams JA, Korc M, Dormer RL. Action of secretagogues on a new preparation of functionally intact, isolated pancreatic acini. Am J Physiol 1978; 253:E517-E524.
18. Logsdon CD, Williams JA. Pancreatic acinar cells in monolayer culture: direct trophic effects of cerulein in vitro. Am J Physiol 1986; 250:G440-G447.
19. Riggins GJ, Kinzler KW, Vogelstein B, Thiagalingam S. Frequency of Smad gene mutations in human cancers. Cancer Res 1997; 57:2578-2580.
20. Mata M, Jin CF, Fink DJ. Axotomy increases CNTF receptor mRNA in rat spinal cord. Brain Res 1993; 610:162-165.
21. Wrana JL, Attisano L, Carcamo J, et al. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 1992; 71:1003-1014.
22. Kalkhoven E. Roelen BA, de Winter JP, et al. Resistance to transforming growth factor b and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ 1995; 6:1151-1161.
23. Lopez-Casillas F, Wrana JL, Massague J. Betaglycan presents ligand to the TGF beta signaling receptor. Cell 1993; 73:1435-1444.
24. Sun L, Chen C. Expression of transforming growth factor β type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells. J Biol Chem 1997; 272:25367-25372.
25. Weis-Garcia F, Massague J. Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J 1996; 15:276-289.
26. Schutte M, Hruban RH, Hedrick L, et al. DPC4 gene in various tumor types. Cancer Res 1996; 56:2527-2530.
27. WAF1 expression and growth inhibition by transforming growth factor β involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res 1997; 57:3929-3934.
28. Wang J, Sun L, Myeroff L, et al. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 1995; 270:22044-22049.
29. Sun L, Wu G, Willson JKV, et al. Expression of transforming growth factor b type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 1994; 269:26449-26455.
30. Friess H, Yamanaka Y, Buchler M, et al. Enhanced expression of the type II transforming growth factor β receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res 1993; 53:2704-2707.
31. Freeman J, Mattingly CA, Strodel WE. Increased tumorigenicity in the human pancreatic cell line MIA PaCa-2 is associated with an aberrant regulation of an IGF-1 autocrine loop and lack of expression of the TGF-beta type II receptor. J Cell Physiol 1995; 165:155-163.
32. DeWinter JP, Roelen B, Dijke P, et al. DPC4 (SMAD4) mediates transforming growth factor-β1 (TGFβ1) induced growth inhibition and transcriptional response in breast tumour cells. Oncogene 1997; 14:1891-1899.
33. Zhou S, Buckhaults P, Zawel L, et al. Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells. Proc Natl Acad Sci U S A 1998; 95:2412-2416.
34. Rodeck U, Nishiyama T, Mauviel A. Independent regulation of growth and SMAD-mediated transcription by transforming growth factor β in human melanoma cells. Cancer Res 1999; 59:547-550.
35. Le Dai J, Schutte M, Bansai RK, et al. Transforming growth factor-β responsiveness in DPC4/SMAD4-null cells. Mol Carcinog 1999; 26: 37-43.